Literature DB >> 17200802

Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis.

Hideto Kameda1, Ayumi Okuyama, Jun-Ichi Tamaru, Shinji Itoyama, Atsushi Iizuka, Tsutomu Takeuchi.   

Abstract

We report on a patient of rheumatoid arthritis (RA) who sequentially developed an axillary mass and a fatal interstitial pneumonia during a 2-year course of methotrexate (MTX) therapy. Autopsy revealed a systemic lymph node involvement and the diagnosis of Epstein-Barr virus (EBV)-related lymphoproliferative disease (LPD) with the features of lymphomatoid granulomatosis was made. The lung tissue specimens revealed a typical diffuse alveolar damage (DAD), and small nodules consisting of atypical B lymphocytes showing positive staining for EBV were sparsely recognized only in basal lungs. This is the first report of a RA patient receiving MTX therapy sequentially developing MTX-associated lymphomatoid granulomatosis and DAD.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17200802     DOI： 10.1007/s10067-006-0480-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  19 in total

1.  Clinical characteristics related to methotrexate-induced pancytopenia.

Authors:  Y Ohosone; Y Okano; H Kameda; N Hama; T Mimori; M Akizuki; Y Ikeda
Journal:  Clin Rheumatol       Date:  1997-05       Impact factor: 2.980

Review 2.  Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.

Authors:  N Kohno
Journal:  J Med Invest       Date:  1999-08

Review 3.  Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment.

Authors:  L Georgescu; G C Quinn; S Schwartzman; S A Paget
Journal:  Semin Arthritis Rheum       Date:  1997-06       Impact factor: 5.532

Review 4.  Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature.

Authors:  G Searles; R J McKendry
Journal:  J Rheumatol       Date:  1987-12       Impact factor: 4.666

5.  Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.

Authors:  Y Ohosone; Y Okano; H Kameda; T Fujii; N Hama; M Hirakata; T Mimori; M Akizuki; Y Ikeda
Journal:  J Rheumatol       Date:  1997-12       Impact factor: 4.666

6.  Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.

Authors:  S Gutierrez-Ureña; J F Molina; C O García; M L Cuéllar; L R Espinoza
Journal:  Arthritis Rheum       Date:  1996-02

Review 7.  Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature.

Authors:  Richard D Baird; Richard Nellis van Zyl-Smit; Timothy Dilke; Sara E Scott; Saad M B Rassam
Journal:  Br J Haematol       Date:  2002-08       Impact factor: 6.998

8.  Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate.

Authors:  C W Carson; G W Cannon; M J Egger; J R Ward; D O Clegg
Journal:  Semin Arthritis Rheum       Date:  1987-02       Impact factor: 5.532

9.  Methotrexate-induced pulmonary lymphoma.

Authors:  Celso T Ebeo; Mirle R Girish; Ryland P Byrd; Thomas M Roy; Jay B Mehta
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

10.  Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.

Authors:  Wen-hai Feng; Jeffrey I Cohen; Steven Fischer; Li Li; Michael Sneller; Raphael Goldbach-Mansky; Nancy Raab-Traub; Henri-Jacques Delecluse; Shannon C Kenney
Journal:  J Natl Cancer Inst       Date:  2004-11-17       Impact factor: 13.506
View more
  11 in total

Review 1.  Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder.

Authors:  Christopher Melani; Elaine S Jaffe; Wyndham H Wilson
Journal:  Blood       Date:  2020-04-16       Impact factor: 22.113

2.  Methotrexate-associated lymphoproliferative disorder complicated by severe acute respiratory failure and ileal perforation:a case report.

Authors:  Eiji Suzuki; Takashi Kanno; Satoru Kimura; Takumi Irie; Hajime Odajima; Kiyoshi Migita
Journal:  Fukushima J Med Sci       Date:  2018-06-19

3.  Lymphomatoid granulomatosis with pulmonary and gastrointestinal involvement.

Authors:  J H Kappen; H C T van Zaanen; S M Snelder; A J P van Tilburg; A Rudolphus
Journal:  BMJ Case Rep       Date:  2017-02-06

4.  Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis.

Authors:  Athar Barakat; Karan Grover; Rohit Peshin
Journal:  Springerplus       Date:  2014-12-18

Review 5.  Histopathological Features of Methotrexate Induced Pulmonary Lesions in Rheumatoid Arthritis Patients: A Systematic Review of Case Reports.

Authors:  Anthony Thaniyan; Foad F A Ayman; Hyder O Mirghani; Badr A Al-Sayed; Tarig H Merghani
Journal:  Open Access Maced J Med Sci       Date:  2017-04-08

Review 6.  The Spontaneous Regression of Grade 3 Methotrexate-related Lymphomatoid Granulomatosis: A Case Report and Literature Review.

Authors:  Naoto Aiko; Akimasa Sekine; Shigeaki Umeda; Takuma Katano; Goshi Matama; Kohsuke Isomoto; Ryota Otoshi; Takashi Ogura
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

Review 7.  Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder.

Authors:  Tatsuyoshi Ikeue; Hiroaki Kawachi; Hiroshi Yoshida; Eiichiro Tanaka; Susumu Noguchi; Akari Fukao; Satoshi Terashita; Tomoko Tajiri; Sadao Horikawa; Takakazu Sugita
Journal:  Intern Med       Date:  2019-02-01       Impact factor: 1.271

Review 8.  Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment.

Authors:  George E Fragoulis; Elena Nikiphorou; Jörg Larsen; Peter Korsten; Richard Conway
Journal:  Front Med (Lausanne)       Date:  2019-10-23

9.  Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.

Authors:  Takeshi Kuroda; Hiroe Sato; Takeshi Nakatsue; Yoko Wada; Shuichi Murakami; Masaaki Nakano; Ichiei Narita
Journal:  BMC Res Notes       Date:  2014-04-11

Review 10.  Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update.

Authors:  Helmut H Popper
Journal:  Virchows Arch       Date:  2012-12-07       Impact factor: 4.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.